Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
appear to be at increased risk for venous thromboembolism (VTE), especially if they become …

Objective Early reports suggest that patients with novel coronavirus disease-2019 (COVID-
19) infection carry a significant risk of altered coagulation with an increased risk for venous …

Introduction The incidence of thromboembolism during COVID-19 and the use of
thromboprophylaxis vary greatly between studies. Only a few studies have investigated the …

Hospitalized patients with coronavirus disease 2019 (COVID-19), particularly those admitted
to the intensive care unit (ICU) are at high risk of morbidity and mortality. Several …

Background Emerging evidence suggests that severe form of coronavirus disease 2019
(COVID-19) is mediated, in part, by a hypercoagulable state characterized by micro-and …

Background Venous thromboembolism (VTE) is a frequent complication of COVID-19, so
that the importance of adequate in-hospital thromboprophylaxis in patients hospitalized with …

Objective To evaluate the clinical course of and risk factors for arterial thrombotic events in
adult inpatients with coronavirus disease 2019 (COVID-19). Methods All consecutive adult …

Background Venous thromboembolism (VTE) is a complication of COVID-19 in hospitalized
patients. Little information is available on long-term outcomes of VTE in this population …

Objective The aim of this study was to evaluate the incidence of deep vein thrombosis (DVT)
of the lower limbs in patients hospitalized with COVID-19 pneumonia in a non-ICU setting …

Background The coronavirus disease 2019 (COVID‐19) is a newly recognized illness that
has spread rapidly all over the world. More and more reports highlight the risk of venous …